We designed Fibrobodies®. These proprietary proteins bind selectively to so-called activated myofibroblasts in any type of fibrotic tissue.
Fibrobodies® support conjugation of a wide range of payloads to create Fibrobody®-drug Conjugates. We are developing a line-up of Fibrobody®-drug conjugates for the diagnosis and treatment of fibrosis of the liver, kidney, lung and gut.
Company Details
- Employees
- 21
- Founded
- 2012
- Address
- Cronenburg 75, Amsterdam,north Holland 1081gm,netherlands
- in****@****als.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- linxispharmaceuticals.com
- Keywords
- Antibody-Drug Conjugates (ADCs), Nanobody-Drug Conjugates (NDCs), Pt-Linker (Lx), Coordination Chemistry.
- HQ
- Amsterdam, North Holland
Linxis Biopharmaceuticals Questions
Linxis Biopharmaceuticals's website is linxispharmaceuticals.com
Linxis Biopharmaceuticals's LinkedIn profile is https://nl.linkedin.com/company/linxispharmaceuticals
Linxis Biopharmaceuticals has
21 employees.
View email and phone details for 21
employees at Linxis Biopharmaceuticals.
Linxis Biopharmaceuticals's industry is
Biotechnology Research
Linxis Biopharmaceuticals's top competitors are
Lumicks,
Scenic Biotech,
Ashcure Pharma B.v.,
Cytokinetics,
Regpak Biopharma,
Phlox Therapeutics,
Kling Biotherapeutics,
Uniqure,
Genecellnano,
Xellera Therapeutics.
Linxis Biopharmaceuticals's support email address is info@linxispharmaceuticals.com
Linxis Biopharmaceuticals's categories are Biotechnology Research
Linxis Biopharmaceuticals's founding year is 2012
